Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr2108, but it redirected us to https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr2108. The analysis below is for the second page.

Title[redir]:
The CD44+/CD24-phenotype is enriched in basal-like breast tumors | Breast Cancer Research | Full Text
Description:
Introduction Human breast tumors are heterogeneous and consist of phenotypically diverse cells. Breast cancer cells with a CD44+/CD24- phenotype have been suggested to have tumor-initiating properties with stem cell-like and invasive features, although it is unclear whether their presence within a tumor has clinical implications. There is also a large heterogeneity between tumors, illustrated by reproducible stratification into various subtypes based on gene expression profiles or histopathological features. We have explored the prevalence of cells with different CD44/CD24 phenotypes within breast cancer subtypes. Methods Double-staining immunohistochemistry was used to quantify CD44 and CD24 expression in 240 human breast tumors for which information on other tumor markers and clinical characteristics was available. Gene expression data were also accessible for a cohort of the material. Results A considerable heterogeneity in CD44 and CD24 expression was seen both between and within tumors. A complete lack of both proteins was evident in 35% of the tumors, while 13% contained cells of more than one of the CD44+/CD24-, CD44-/CD24+ and CD44+/CD24+ phenotypes. CD44+/CD24- cells were detected in 31% of the tumors, ranging in proportion from only a few to close to 100% of tumor cells. The CD44+/CD24- phenotype was most common in the basal-like subgroup – characterized as negative for the estrogen and progesterone receptors as well as for HER2, and as positive for cytokeratin 5/14 and/or epidermal growth factor receptor, and particularly common in BRCA1 hereditary tumors, of which 94% contained CD44+/CD24- cells. The CD44+/CD24- phenotype was surprisingly scarce in HER2+ tumors, which had a predominantly CD24+ status. A CD44+/CD24- gene expression signature was generated, which included CD44 and α6-integrin (CD49f) among the top-ranked overexpressed genes. Conclusion We demonstrate an association between basal-like and particularly BRCA1 hereditary breast cancer and the presence of CD44+/CD24- cells. Not all basal-like tumors and very few HER2+ tumors, however, contain CD44+/CD24- cells, emphasizing that a putative tumorigenic ability may not be confined to cells of this phenotype and that other breast cancer stem cell markers remain to be identified.

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 91,115,781 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure how the site profits.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Doi.org has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

cells, tumors, cdcd, breast, cancer, tumor, expression, pubmed, article, google, scholar, gene, basallike, phenotype, cas, positive, status, staining, cell, srher, table, data, clinical, receptor, correlation, subgroups, analysis, presence, subtypes, patients, res, detected, brca, study, central, stem, proportion, survival, authors, human, characteristics, signature, subtype, results, subgroup, genes, lund, colleagues, size, markers,

Topics {✒️}

springer nature references al-hajj figures 1a estrogen-receptor-negative breast cancers er-negative stem/progenitor cells materials author information authors stem/progenitor cell properties paraffin-embedded tumor tissue brca1-defective breast tumors distant disease-free survival putative tumor-initiating cells human breast tumours maintain tumor growth intra-tumoral heterogeneity resulting cytokeratin clone ae1/ae3 eralpha-negative breast carcinoma human breast carcinoma rijn van de her2/neu-overexpressing phenotypes distinct characteristics authors scientific editing authors’ original file human breast tumors swedish research council adjacent sections privacy choices/manage cookies bmc genomics full size table invasive breast carcinomas immunohistochemistry-based pilot study clinical cancer research top-ranked overexpressed genes cd44+/cd24- tumor cells cd44-/cd24+ tumor cells long-term follow predominantly cd44+/cd24- cells stem/progenitor cells swedish cancer society gruvberger-saal sk natl cancer inst cd44+/cd24-/low cells additional tma consisting brca1 hereditary tumors breast cancer res breast cancer cells brca1 tissue microarray cancer stem cells invasive breast cancers expressed cd44+/cd24- cells

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The CD44+/CD24-phenotype is enriched in basal-like breast tumors
         description:Human breast tumors are heterogeneous and consist of phenotypically diverse cells. Breast cancer cells with a CD44+/CD24- phenotype have been suggested to have tumor-initiating properties with stem cell-like and invasive features, although it is unclear whether their presence within a tumor has clinical implications. There is also a large heterogeneity between tumors, illustrated by reproducible stratification into various subtypes based on gene expression profiles or histopathological features. We have explored the prevalence of cells with different CD44/CD24 phenotypes within breast cancer subtypes. Double-staining immunohistochemistry was used to quantify CD44 and CD24 expression in 240 human breast tumors for which information on other tumor markers and clinical characteristics was available. Gene expression data were also accessible for a cohort of the material. A considerable heterogeneity in CD44 and CD24 expression was seen both between and within tumors. A complete lack of both proteins was evident in 35% of the tumors, while 13% contained cells of more than one of the CD44+/CD24-, CD44-/CD24+ and CD44+/CD24+ phenotypes. CD44+/CD24- cells were detected in 31% of the tumors, ranging in proportion from only a few to close to 100% of tumor cells. The CD44+/CD24- phenotype was most common in the basal-like subgroup – characterized as negative for the estrogen and progesterone receptors as well as for HER2, and as positive for cytokeratin 5/14 and/or epidermal growth factor receptor, and particularly common in BRCA1 hereditary tumors, of which 94% contained CD44+/CD24- cells. The CD44+/CD24- phenotype was surprisingly scarce in HER2+ tumors, which had a predominantly CD24+ status. A CD44+/CD24- gene expression signature was generated, which included CD44 and α6-integrin (CD49f) among the top-ranked overexpressed genes. We demonstrate an association between basal-like and particularly BRCA1 hereditary breast cancer and the presence of CD44+/CD24- cells. Not all basal-like tumors and very few HER2+ tumors, however, contain CD44+/CD24- cells, emphasizing that a putative tumorigenic ability may not be confined to cells of this phenotype and that other breast cancer stem cell markers remain to be identified.
         datePublished:2008-06-17T00:00:00Z
         dateModified:2008-06-17T00:00:00Z
         pageStart:1
         pageEnd:12
         license:http://creativecommons.org/licenses/by/2.0/
         sameAs:https://doi.org/10.1186/bcr2108
         keywords:
            Epidermal Growth Factor Receptor
            Human Breast Tumor
            Breast Cancer Subgroup
            BRCA1 Germline Mutation Carrier
            Distinct Genetic Profile
            Cancer Research
            Oncology
            Surgical Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2108/MediaObjects/13058_2008_2072_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2108/MediaObjects/13058_2008_2072_Fig2_HTML.jpg
         isPartOf:
            name:Breast Cancer Research
            issn:
               1465-542X
            volumeNumber:10
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Gabriella Honeth
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Pär-Ola Bendahl
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Markus Ringnér
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:CREATE Health Strategic Centre for Clinical Cancer Research
                     address:
                        name:CREATE Health Strategic Centre for Clinical Cancer Research, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lao H Saal
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Columbia University
                     address:
                        name:Institute for Cancer Genetics, Columbia University, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sofia K Gruvberger-Saal
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Columbia University
                     address:
                        name:Institute for Cancer Genetics, Columbia University, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kristina Lövgren
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dorthe Grabau
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Pathology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mårten Fernö
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Åke Borg
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:CREATE Health Strategic Centre for Clinical Cancer Research
                     address:
                        name:CREATE Health Strategic Centre for Clinical Cancer Research, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy
                     address:
                        name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Cecilia Hegardt
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:CREATE Health Strategic Centre for Clinical Cancer Research
                     address:
                        name:CREATE Health Strategic Centre for Clinical Cancer Research, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy
                     address:
                        name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The CD44+/CD24-phenotype is enriched in basal-like breast tumors
      description:Human breast tumors are heterogeneous and consist of phenotypically diverse cells. Breast cancer cells with a CD44+/CD24- phenotype have been suggested to have tumor-initiating properties with stem cell-like and invasive features, although it is unclear whether their presence within a tumor has clinical implications. There is also a large heterogeneity between tumors, illustrated by reproducible stratification into various subtypes based on gene expression profiles or histopathological features. We have explored the prevalence of cells with different CD44/CD24 phenotypes within breast cancer subtypes. Double-staining immunohistochemistry was used to quantify CD44 and CD24 expression in 240 human breast tumors for which information on other tumor markers and clinical characteristics was available. Gene expression data were also accessible for a cohort of the material. A considerable heterogeneity in CD44 and CD24 expression was seen both between and within tumors. A complete lack of both proteins was evident in 35% of the tumors, while 13% contained cells of more than one of the CD44+/CD24-, CD44-/CD24+ and CD44+/CD24+ phenotypes. CD44+/CD24- cells were detected in 31% of the tumors, ranging in proportion from only a few to close to 100% of tumor cells. The CD44+/CD24- phenotype was most common in the basal-like subgroup – characterized as negative for the estrogen and progesterone receptors as well as for HER2, and as positive for cytokeratin 5/14 and/or epidermal growth factor receptor, and particularly common in BRCA1 hereditary tumors, of which 94% contained CD44+/CD24- cells. The CD44+/CD24- phenotype was surprisingly scarce in HER2+ tumors, which had a predominantly CD24+ status. A CD44+/CD24- gene expression signature was generated, which included CD44 and α6-integrin (CD49f) among the top-ranked overexpressed genes. We demonstrate an association between basal-like and particularly BRCA1 hereditary breast cancer and the presence of CD44+/CD24- cells. Not all basal-like tumors and very few HER2+ tumors, however, contain CD44+/CD24- cells, emphasizing that a putative tumorigenic ability may not be confined to cells of this phenotype and that other breast cancer stem cell markers remain to be identified.
      datePublished:2008-06-17T00:00:00Z
      dateModified:2008-06-17T00:00:00Z
      pageStart:1
      pageEnd:12
      license:http://creativecommons.org/licenses/by/2.0/
      sameAs:https://doi.org/10.1186/bcr2108
      keywords:
         Epidermal Growth Factor Receptor
         Human Breast Tumor
         Breast Cancer Subgroup
         BRCA1 Germline Mutation Carrier
         Distinct Genetic Profile
         Cancer Research
         Oncology
         Surgical Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2108/MediaObjects/13058_2008_2072_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2108/MediaObjects/13058_2008_2072_Fig2_HTML.jpg
      isPartOf:
         name:Breast Cancer Research
         issn:
            1465-542X
         volumeNumber:10
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Gabriella Honeth
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Pär-Ola Bendahl
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Markus Ringnér
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:CREATE Health Strategic Centre for Clinical Cancer Research
                  address:
                     name:CREATE Health Strategic Centre for Clinical Cancer Research, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lao H Saal
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Columbia University
                  address:
                     name:Institute for Cancer Genetics, Columbia University, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sofia K Gruvberger-Saal
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Columbia University
                  address:
                     name:Institute for Cancer Genetics, Columbia University, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kristina Lövgren
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dorthe Grabau
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Pathology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mårten Fernö
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Åke Borg
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:CREATE Health Strategic Centre for Clinical Cancer Research
                  address:
                     name:CREATE Health Strategic Centre for Clinical Cancer Research, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy
                  address:
                     name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Cecilia Hegardt
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:CREATE Health Strategic Centre for Clinical Cancer Research
                  address:
                     name:CREATE Health Strategic Centre for Clinical Cancer Research, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy
                  address:
                     name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research
      issn:
         1465-542X
      volumeNumber:10
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:CREATE Health Strategic Centre for Clinical Cancer Research
      address:
         name:CREATE Health Strategic Centre for Clinical Cancer Research, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Columbia University
      address:
         name:Institute for Cancer Genetics, Columbia University, New York, USA
         type:PostalAddress
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Columbia University
      address:
         name:Institute for Cancer Genetics, Columbia University, New York, USA
         type:PostalAddress
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:Department of Pathology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:CREATE Health Strategic Centre for Clinical Cancer Research
      address:
         name:CREATE Health Strategic Centre for Clinical Cancer Research, Lund, Sweden
         type:PostalAddress
      name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy
      address:
         name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:CREATE Health Strategic Centre for Clinical Cancer Research
      address:
         name:CREATE Health Strategic Centre for Clinical Cancer Research, Lund, Sweden
         type:PostalAddress
      name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy
      address:
         name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund, Sweden
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Gabriella Honeth
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Pär-Ola Bendahl
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Markus Ringnér
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:CREATE Health Strategic Centre for Clinical Cancer Research
            address:
               name:CREATE Health Strategic Centre for Clinical Cancer Research, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Lao H Saal
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Columbia University
            address:
               name:Institute for Cancer Genetics, Columbia University, New York, USA
               type:PostalAddress
            type:Organization
      name:Sofia K Gruvberger-Saal
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Columbia University
            address:
               name:Institute for Cancer Genetics, Columbia University, New York, USA
               type:PostalAddress
            type:Organization
      name:Kristina Lövgren
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Dorthe Grabau
      affiliation:
            name:Lund University
            address:
               name:Department of Pathology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Mårten Fernö
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Åke Borg
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:CREATE Health Strategic Centre for Clinical Cancer Research
            address:
               name:CREATE Health Strategic Centre for Clinical Cancer Research, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy
            address:
               name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Cecilia Hegardt
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:CREATE Health Strategic Centre for Clinical Cancer Research
            address:
               name:CREATE Health Strategic Centre for Clinical Cancer Research, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy
            address:
               name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund, Sweden
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:CREATE Health Strategic Centre for Clinical Cancer Research, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:Institute for Cancer Genetics, Columbia University, New York, USA
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:Institute for Cancer Genetics, Columbia University, New York, USA
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:Department of Pathology, Clinical Sciences, Lund University, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:CREATE Health Strategic Centre for Clinical Cancer Research, Lund, Sweden
      name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:CREATE Health Strategic Centre for Clinical Cancer Research, Lund, Sweden
      name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund, Sweden

External Links {🔗}(331)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

4.43s.